Hydrocodone Bitartrate and Homatropine Methylbromide
- Product NDC
- 64950-371
- 11-digit product format
- 649500371
- Labeler code
- 64950
- Product ID
- 64950-371_d2e40c65-781a-410f-a6e1-5fe01b76c24f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrocodone Bitartrate and Homatropine Methylbromide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Genus Lifesciences Inc.
- Application
- NDA005213
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-08-10
- Substance
- HYDROCODONE BITARTRATE; HOMATROPINE METHYLBROMIDE
- Active strength
- 5; 1.5 mg/5mL; mg/5mL
- Pharmacologic classes
- Opioid Agonist [EPC], Opioid Agonists [MoA]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N005213-001 | HYCODAN | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 |
| N005213-002 | HYCODAN | HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N005213-001 | AA |
| N005213-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N005213-001 | HYCODAN | 1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | AA | RLD | 1988-07-26 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SYRUP / ORAL | AA | RLD | 1988-07-26 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N005213-001 | HYCODAN | 1.5MG;5MG | TABLET / ORAL | AA | RLD | 1988-07-26 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | AA | RLD | 1988-07-26 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N005213-001 | HYCODAN | 1.5MG;5MG | TABLET / ORAL | AA | RLD | 1988-07-26 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N005213-002 | HYCODAN | 1.5MG/5ML;5MG/5ML | SYRUP / ORAL | AA | RLD | 1988-07-26 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N005213-002 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N005213-001 | AA | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N005213-002 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N005213-001 | AA | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N005213-002 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N005213-002 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N005213-002 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N005213-002 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N005213-002 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N005213-002 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N005213-002 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N005213-002 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N005213-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N005213-002 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N005213-001 | AA | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N005213-002 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N005213-001 | AA | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N005213-002 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N005213-001 | AA | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N005213-002 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N005213-001 | AA | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N005213-002 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N005213-001 | AA | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N005213-002 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N005213-001 | AA | 1 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N005213-002 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N005213-001 | AA | 1 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N005213-002 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N005213-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N005213-002 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N005213-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N005213-002 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N005213-001 | AA | 1 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N005213-002 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N005213-001 | AA | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N005213-002 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N005213-001 | AA | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N005213-002 | AA | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N005213-001 | AA | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N005213-002 | AA | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydrocodone Bitartrate and Homatropine Methylbromide
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROCODONE BITARTRATE | 5 mg/5mL |
| HOMATROPINE METHYLBROMIDE | 1.5 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 68JRS2HC1C | Internal UNII lookup |
| NO70W886KK | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 320ff639-9854-407b-9bbd-a035c4f173e1 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64950-371-47 | Hydrocodone Bitartrate and Homatropine Methylbromide | 473 mL in 1 BOTTLE | SOLUTION | 473 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64950-371-47 | ML - Milliliter | 64950-371 | a76b937c-2b83-473d-967c-e1bae783c562 | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64950-371 | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLET HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE SOLUTION [GENUS LIFESCIENCES INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220825_320ff639-9854-407b-9bbd-a035c4f173e1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | Genus Lifesciences Inc. | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 005213 NDA005213 64950-371 |
| Hydrocodone Bitartrate and Homatropine Methylbromide | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | PAI Holdings, LLC dba PAI Pharma | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 2026-02-28 | Boxed warning, Warnings, Adverse reactions | 005213 NDA005213 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 992668 | HYDROcodone bitartrate 5 MG / homatropine methylbromide 1.5 MG in 5 mL Oral Solution | PSN | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2 |
| 992656 | HYDROcodone bitartrate 5 MG / homatropine methylbromide 1.5 MG Oral Tablet | PSN | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2 |
| 992668 | homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution | SCD | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2 |
| 992656 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG Oral Tablet | SCD | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2 |
| 992668 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Syrup | SY | 320ff639-9854-407b-9bbd-a035c4f173e1 | 2 |
| 992668 | HYDROcodone bitartrate 5 MG / homatropine methylbromide 1.5 MG in 5 mL Oral Solution | PSN | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 1 |
| 992668 | homatropine methylbromide 0.3 MG/ML / hydrocodone bitartrate 1 MG/ML Oral Solution | SCD | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 1 |
| 992668 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Syrup | SY | 71319a6f-aaf4-4bc5-8b40-a16c6f139be6 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 64950-371-47 | 64950037147 | 473 mL in 1 BOTTLE (64950-371-47) | 473 ml | 2022-08-10 | 0000-00-00 | No | No | Current |